A detailed history of Xponance, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 29,321 shares of ADMA stock, worth $621,018. This represents 0.01% of its overall portfolio holdings.

Number of Shares
29,321
Previous 18,468 58.77%
Holding current value
$621,018
Previous $206,000 184.47%
% of portfolio
0.01%
Previous 0.0%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$11.21 - $20.03 $121,662 - $217,385
10,853 Added 58.77%
29,321 $586,000
Q2 2024

Aug 14, 2024

BUY
$5.98 - $11.18 $33,470 - $62,574
5,597 Added 43.49%
18,468 $206,000
Q1 2024

May 13, 2024

SELL
$4.4 - $6.74 $580 - $889
-132 Reduced 1.02%
12,871 $84,000
Q4 2023

Jan 31, 2024

SELL
$3.08 - $4.52 $1,167 - $1,713
-379 Reduced 2.83%
13,003 $58,000
Q3 2023

Oct 23, 2023

BUY
$3.47 - $4.61 $784 - $1,041
226 Added 1.72%
13,382 $47,000
Q2 2023

Jul 13, 2023

BUY
$3.12 - $4.22 $3,965 - $5,363
1,271 Added 10.69%
13,156 $48,000
Q1 2023

Apr 17, 2023

BUY
$3.01 - $3.87 $3,900 - $5,015
1,296 Added 12.24%
11,885 $39,000
Q4 2022

Jan 23, 2023

BUY
$2.47 - $3.88 $513 - $807
208 Added 2.0%
10,589 $0
Q3 2022

Oct 24, 2022

BUY
$2.03 - $2.86 $606 - $855
299 Added 2.97%
10,381 $25,000
Q2 2022

Aug 02, 2022

BUY
$1.43 - $2.2 $14,417 - $22,180
10,082 New
10,082 $20,000

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $4.16B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.